Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study.
Baltas I, Gilchrist M, Koutoumanou E, Gibani MM, Meiring JE, Otu A, Hettle D, Thompson A, Price JR, Crepet A, Atomode A, Crocker-Buque T, Spinos D, Guyver H, Tausan M, Somasunderam D, Thoburn M, Chan C, Umpleby H, Sharp B, Chivers C, Vaghela DS, Shah RJ, Foster J, Hume A, Smith C, Asif A, Mermerelis D, Reza MA, Haigh DA, Lamb T, Karatzia L, Bramley A, Kadam N, Kavallieros K, Garcia-Arias V, Democratis J, Waddington CS, Moore LSP, Aiken AM. Baltas I, et al. Among authors: gibani mm. JAC Antimicrob Resist. 2023 Aug 1;5(4):dlad091. doi: 10.1093/jacamr/dlad091. eCollection 2023 Aug. JAC Antimicrob Resist. 2023. PMID: 37533762 Free PMC article.
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group. RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, et al. Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.
How to develop a controlled human infection model for Clostridioides difficile.
Hensen ADO, Vehreschild MJGT, Gerding DN, Krut O, Chen W, Young VB, Tzipori S, Solbach P, Gibani MM, Chiu C, de Keersmaecker SCJ, Dasyam D, Morel S, Devaster JM, Corti N, Kuijper EJ, Roestenberg M, Smits WK. Hensen ADO, et al. Among authors: gibani mm. Clin Microbiol Infect. 2024 Aug 29:S1198-743X(24)00425-7. doi: 10.1016/j.cmi.2024.08.025. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39214188 Free article. Review.
The effect of ciprofloxacin prophylaxis during haematopoietic cell transplantation on infection episodes, exposure to treatment antimicrobials and antimicrobial resistance: a single-centre retrospective cohort study.
Baltas I, Kavallieros K, Konstantinou G, Koutoumanou E, Gibani MM, Gilchrist M, Davies F, Pavlu J. Baltas I, et al. Among authors: gibani mm. JAC Antimicrob Resist. 2024 Feb 1;6(1):dlae010. doi: 10.1093/jacamr/dlae010. eCollection 2024 Feb. JAC Antimicrob Resist. 2024. PMID: 38304723 Free PMC article.
Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK.
Smith C, Smith E, Rydlova A, Varro R, Hinton JCD, Gordon MA, Choy RKM, Liu X, Pollard AJ, Chiu C, Cooke GS, Gibani MM. Smith C, et al. Among authors: gibani mm. BMJ Open. 2024 Jan 10;14(1):e076477. doi: 10.1136/bmjopen-2023-076477. BMJ Open. 2024. PMID: 38199617 Free PMC article.
The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK.
Smith C, Smith E, Chiu C, Hinton J, Perez Sepulveda B, Gordon M, Choy RKM, Hill PWS, Meiring JE, Darton TC, Carey ME, Cooke G, Gibani MM; CHANTS Consortium. Smith C, et al. Among authors: gibani mm. Wellcome Open Res. 2023 Sep 21;8:111. doi: 10.12688/wellcomeopenres.19012.2. eCollection 2023. Wellcome Open Res. 2023. PMID: 37808389 Free PMC article.
Early transcriptional responses to human enteric fever challenge.
Barton A, Hill J, O'Connor D, Jones C, Jones E, Camara S, Shrestha S, Jin C, Gibani MM, Dobinson HC, Waddington C, Darton TC, Blohmke CJ, Pollard AJ. Barton A, et al. Among authors: gibani mm. Infect Immun. 2023 Oct 17;91(10):e0010823. doi: 10.1128/iai.00108-23. Epub 2023 Sep 19. Infect Immun. 2023. PMID: 37725060 Free PMC article.
Molecular correlates of vaccine-induced protection against typhoid fever.
Zhu H, Chelysheva I, Cross DL, Blackwell L, Jin C, Gibani MM, Jones E, Hill J, Trück J, Kelly DF, Blohmke CJ, Pollard AJ, O'Connor D. Zhu H, et al. Among authors: gibani mm. J Clin Invest. 2023 Aug 15;133(16):e169676. doi: 10.1172/JCI169676. J Clin Invest. 2023. PMID: 37402153 Free PMC article. Clinical Trial.
The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohort.
Rimmer S, Barnacle J, Gibani MM, Wu MS, Dissanayake O, Mehta R, Herdman T, Gilchrist M, Muir D, Ebrahimsa U, Mora-Peris B, Dosekun O, Garvey L, Peters J, Davies F, Cooke G, Abbara A. Rimmer S, et al. Among authors: gibani mm. Int J Infect Dis. 2023 Jan;126:48-53. doi: 10.1016/j.ijid.2022.11.020. Epub 2022 Nov 19. Int J Infect Dis. 2023. PMID: 36410691 Free PMC article.
39 results